Skip to main content
Premium Trial:

Request an Annual Quote

Rich Keffer, Frank Oaks, Michael Barber

Sigma-Aldrich has named Rich Keffer to the post of corporate vice president, general counsel, and secretary, effective Aug. 28. In his new role, Keffer will manage the firm’s legal services and corporate governance processes.
 
Keffer’s most recent general counsel experience was with D&K Healthcare, which was acquired by McKesson in 2005.
 

 
Solexa appointed Frank Oaks as vice president of DNA sequencing services, the company said last week. as vice president of DNA sequencing services, the company said last week.
 
Oaks joined Solexa from Applied Biosystems’ Genetic Analysis Group, where he was most recently director of scientific operations. Prior to ABI, he was a research scientist with Dow Chemical. ’ Genetic Analysis Group, where he was most recently director of scientific operations. Prior to ABI, he was a research scientist with .
 
He holds a PhD in organic chemistry from the University of Wisconsin, a BS in chemistry from the University of California, Los Angeles, and an MBA from Santa Clara University. 
 

 
Bruker BioSciences’ board of directors modified the compensation plan for non-employee directors on Aug. 1, the company said in documents filed with the Securities and Exchange Commission last week.
 
The annual retainer for non-employee directors increased to $26,000 from $16,000, the filing said. Each non-employee director will also receive a payment of $1,500 per board meeting the director attends, either in-person or by phone. They will continue to receive stock options.
 
The audit committee’s chairman receives an additional cash retainer, the amount of which increased to $28,000 from $18,000. The additional retainer the other members of the committee receive increased to $13,000 from $6,000.
 
The compensation committee’s chairman also receives an additional cash retainer, which increased to $13,000 from $6,000. The other committee members’ retainers increase to $8,000 from $4,000. 
 

 
GE has appointed Michael Barber to the position of chief technology officer of GE Healthcare and a vice president of technology, diagnostic imaging. He has been the general manager of technology since May 2005 and has been with GE since 1981. He held other positions in GE Healthcare, including general manager for components engineering and general manager for global components operations.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.